Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regrafts.

Y Iwaki, R Y Cho, P I Terasaki

    Clinical Transplants
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Kidney regraft survival rates are improving, with one-year patient survival reaching 93%. However, immunosuppressive drug benefits were less pronounced for regrafts compared to first kidney transplants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Landsteiner Award. HLA epitope matching.

    Transfusion·1992
    Same author

    HLA matching effect on five-year graft survival and half-life in the cyclosporine era.

    Kidney international. Supplement·1992
    Same author

    Prolongation of second heart transplants in rats.

    Transplantation·1992
    Same author

    Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.

    The New England journal of medicine·1992
    Same author

    Effect of mismatching serologically defined residues on kidney transplant survival.

    Transplantation proceedings·1992
    Same author

    Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States.

    Transplantation proceedings·1992
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Transplantation Immunology
    • Clinical Outcomes

    Background:

    • Kidney transplantation is a vital treatment for end-stage renal disease.
    • Understanding factors influencing regraft survival is crucial for optimizing patient outcomes.

    Purpose of the Study:

    • To analyze trends in kidney regraft survival and patient survival over time.
    • To evaluate the impact of recipient age, sensitization, and first graft duration on regraft success.

    Main Methods:

    • Retrospective analysis of kidney transplant patient and graft survival data.
    • Comparison of outcomes for first grafts versus regrafts.
    • Assessment of variables including recipient age, pre-transplant sensitization, and duration of first graft function.

    Related Experiment Videos

    Main Results:

    • One-year patient survival for regrafted kidney patients improved significantly, reaching 93% by 1986.
    • Regraft survival rates showed steady improvement but were less impacted by Cyclosporine A (CsA) compared to first grafts.
    • Longer duration of the first functioning graft was strongly associated with better outcomes for subsequent regrafts.

    Conclusions:

    • Kidney regraft outcomes demonstrate a positive trend, with significant improvements in both patient and graft survival.
    • First graft duration is a critical predictor of regraft success, highlighting the importance of preserving initial graft function.
    • Recipient age and sensitization status influence first graft outcomes but have less impact on regrafts in already sensitized patients.